Navigation Links
NOVAVAX Announces Issuance of Key U.S. Patent for Influenza Virus-Like Particle (VLP) Vaccines
Date:7/27/2010

at Novavax and one of the senior inventors of the VLP technology.

"This patent strengthens our competitive position around our core technology that allows us to produce recombinant influenza VLP vaccines.  We are grateful to our scientific team that pioneered this innovative and elegant approach to manufacturing efficient, high-quality, immunogenic influenza vaccines," said Dr. Rahul Singhvi, President and CEO of Novavax.

About Novavax

Novavax, Inc. is a clinical-stage biopharmaceutical company creating novel vaccines to address a broad range of infectious diseases worldwide, including H1N1, using advanced proprietary virus-like-particle (VLP) technology. The company produces potent VLP-based recombinant vaccines utilizing new and efficient manufacturing approaches. Novavax is committed to using its VLP technology to create country-specific vaccine solutions. The company has formed a joint venture with Cadila Pharmaceuticals, named CPL Biologicals, to develop and manufacture vaccines, biological therapeutics and diagnostics in India. Additional information about Novavax is available on the company's website: www.novavax.com.

Forward Looking Statement

Statements herein relating to future development results and performance, conditions or strategies and other matters, including expectations regarding product and clinical developments, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act. Novavax cautions that these forward-looking statements are subject to numerous assump
'/>"/>

SOURCE Novavax, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Novavax CEO to Present at Phacilitate Vaccine Forum Barcelona 2010
2. Novavaxs Seasonal Influenza VLP Vaccine Candidate Shows Positive Results in a Phase II Clinical Trial in Older Adults
3. NOVAVAX Reports Fourth Quarter and 2009 Year-End Financial Results
4. NOVAVAX to Present at 22nd Annual ROTH OC Growth Stock Conference
5. NOVAVAX to Present at Cowen and Companys 30th Annual Health Care Conference
6. NOVAVAX Reports Additional Positive Data from Its Trivalent Seasonal Influenza (VLP) Vaccine Clinical Study in Healthy Adults
7. Novavax Terminates Negotiations with ROVI Pharmaceuticals for Influenza Vaccine Collaboration
8. NOVAVAX Announces Closing of Public Offering of 6,800,000 Shares of Common Stock
9. NOVAVAX Reports Positive Clinical Results from Pivotal Study of H1N1 Influenza Vaccine in Mexico
10. Novavax to Present at 8th Annual BIO Investor Forum 2009
11. Novavax Launches Pivotal Clinical Study of Novel 2009 H1N1 VLP Flu Vaccine in Mexico
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)...  Varian Medical Systems (NYSE: VAR ) ... share in the third quarter of fiscal year 2014.  ... diluted share due to an approximately $8 million impairment ... investment in Augmenix, a privately-held company developing minimally invasive ... for the third quarter of fiscal year 2014, up ...
(Date:7/23/2014)... , July 23, 2014 UBM Medica ... – a new online community and information resource for ... manage and treat their patients with neurological disorders ... with an aging population, necessitates greater access to dedicated ...  Key statistics on neurological conditions include: , ...
(Date:7/23/2014)... , July 23, 2014 The Board of ... a leading provider of clinical trial imaging solutions, announced ... been named president and chief executive officer, effective immediately.  ... August 2013 and has held the positions of interim ... Dr. Charles E. Phelps , Ph.D., ...
Breaking Medicine Technology:Varian Medical Systems Reports Results for Third Quarter of Fiscal Year 2014 2Varian Medical Systems Reports Results for Third Quarter of Fiscal Year 2014 3Varian Medical Systems Reports Results for Third Quarter of Fiscal Year 2014 4Varian Medical Systems Reports Results for Third Quarter of Fiscal Year 2014 5Varian Medical Systems Reports Results for Third Quarter of Fiscal Year 2014 6Varian Medical Systems Reports Results for Third Quarter of Fiscal Year 2014 7Varian Medical Systems Reports Results for Third Quarter of Fiscal Year 2014 8Varian Medical Systems Reports Results for Third Quarter of Fiscal Year 2014 9Varian Medical Systems Reports Results for Third Quarter of Fiscal Year 2014 10UBM Medica US Launches NeurologyTimes.com 2UBM Medica US Launches NeurologyTimes.com 3Eric T. Converse Named President And Chief Executive Officer Of VirtualScopics, Inc. 2Eric T. Converse Named President And Chief Executive Officer Of VirtualScopics, Inc. 3Eric T. Converse Named President And Chief Executive Officer Of VirtualScopics, Inc. 4
... International, Inc., (OTC Bulletin Board: OXIS ; ... conference call with investors on Tuesday, March 22, 2011 ... During the call Anthony Cataldo, Chief Executive Officer, and ... the Company,s growth strategy, and take questions from call ...
... LA JOLLA, Calif., March 9, 2011 Scientific ... the foundation for the new drug Benlysta® (belimumab), approved today ... the most common type of lupus, is the first in ... attacking its own critical tissues. "I am deeply ...
Cached Medicine Technology:New Lupus Drug Results From Scripps Research Technology 2New Lupus Drug Results From Scripps Research Technology 3New Lupus Drug Results From Scripps Research Technology 4
(Date:7/23/2014)... Dotinga HealthDay Reporter ... drug combo may not be as effective against cystic ... cells suggests that one of the medications might stop ... findings aren,t definitive, and there,s still hope for the ... according to the study,s senior author. "The development ...
(Date:7/23/2014)... Steven Reinberg HealthDay Reporter ... obese and overweight American children and teens look in ... U.S. health officials reported Wednesday. "Being overweight or ... high blood pressure, high cholesterol and diabetes," said lead ... Centers for Disease Control and Prevention,s National Center for ...
(Date:7/23/2014)... if a suspicious skin lesion is painful or itchy ... to be cancerous, according to a new study headed ... Dermatology at Temple University School of Medicine. , The ... July 23, 2014, found that nearly 36. 9 percent ... 28.2 percent involve pain. Non-melanoma skin cancers specifically, ...
(Date:7/23/2014)... The next episode of “Extreme Weight Loss” Season ... physically fit through childhood and adolescence. After becoming pregnant ... decision to give her son up for adoption. That ... and she punished herself by overeating, gaining nearly 200 ... approach to weight loss transformations, “Extreme Weight Loss” airs ...
(Date:7/23/2014)... July 23, 2014 Celebrating a decade ... Jersey today announced the awarding of $1,070,000 in grants ... award in recognition of the Foundation’s 1,000th grant. , ... continue our tradition of supporting community-based organizations that are ... of life in the Garden State,” said Robert A. ...
Breaking Medicine News(10 mins):Health News:Cystic Fibrosis Drug Combo May Be Less Effective Than Hoped 2Health News:Cystic Fibrosis Drug Combo May Be Less Effective Than Hoped 3Health News:Many Obese U.S. Kids Think They're Thinner Than They Are 2Health News:Many Obese U.S. Kids Think They're Thinner Than They Are 3Health News:Research led by Temple's chair of dermatology: Pain and itch may be signs of skin cancer 2Health News:“Extreme Weight Loss”: Cassie’s journey begins at the University of Colorado Anschutz Health and Wellness Center 2Health News:The Horizon Foundation for New Jersey Awards More than $1 million in Grants to 20 Non-profit Organizations 2Health News:The Horizon Foundation for New Jersey Awards More than $1 million in Grants to 20 Non-profit Organizations 3Health News:The Horizon Foundation for New Jersey Awards More than $1 million in Grants to 20 Non-profit Organizations 4Health News:The Horizon Foundation for New Jersey Awards More than $1 million in Grants to 20 Non-profit Organizations 5
... ... Bill Schmalfeldt thought his story was worth telling. After being diagnosed with ... Bill wrote a manuscript about the experience. Not only could he not ... it without even reading sample chapters. Believing the story needed to be ...
... ... Introduces Newest, Safest Method of Liposuction , ... NEW YORK, NY (PRWEB) July 1, 2010 -- Dr. Daniel ... approved liposuction procedure, called Nutational Infrasonic Liposuction, more commonly known as Tickle Lipo™. ...
... of medicine,s most successful transplant procedures, doctors continue to ... first time, a team of German and British researchers ... are more likely in patients whose eyes exhibit abnormal ... meta-analysis report appears in July Ophthalmology , the ...
... ... Network of Uganda proudly announces a new fund-raising campaign - ... support of families living with HIV/AIDS and extreme poverty in Uganda. The ... educate their children and provide them with additional nutritional support. The ...
... Reporter , WEDNESDAY, June 30 (HealthDay News) -- Researchers ... areata, a disorder that causes hair to thin and ... other autoimmune diseases, including rheumatoid arthritis and type 1 ... pipeline that could benefit people with hair loss, the ...
... Diane von Furstenberg is ... the 2010 Life Ball on July 17th, 2010 , ... New York, NY (PRWEB) June 30, 2010 -- Diane von Furstenberg is pleased to ... Life Ball on July 17th, 2010., , ,“There is nothing more New York than the Radio ...
Cached Medicine News:Health News:Parkinson's Disease Patient Tells Personal Story to Benefit PD Research; Donates Book Proceeds to PD Charities 2Health News:Parkinson's Disease Patient Tells Personal Story to Benefit PD Research; Donates Book Proceeds to PD Charities 3Health News:Parkinson's Disease Patient Tells Personal Story to Benefit PD Research; Donates Book Proceeds to PD Charities 4Health News:Dr. Daniel Ronel is one of the First in the U.S. to Offer Tickle Lipo™ 2Health News:Dr. Daniel Ronel is one of the First in the U.S. to Offer Tickle Lipo™ 3Health News:Study finds new key to corneal transplant success 2Health News:Mulago Positive Women's Network Announce Their "BONO" Bracelet Fundraiser to Benefit HIV+ Women in Uganda 2Health News:Mulago Positive Women's Network Announce Their "BONO" Bracelet Fundraiser to Benefit HIV+ Women in Uganda 3Health News:Genes Tied to Hair Loss Disorder 2Health News:Genes Tied to Hair Loss Disorder 3Health News:DVF To Bring The Radio City Rockettes To Vienna's Life Ball 2Health News:DVF To Bring The Radio City Rockettes To Vienna's Life Ball 3
Fully lined with cotton material for extra softness against patients skin. The 3 double adjustable soft Velcro® bands provide vertical/downward pressure for adjustable comfort following submuscu...
This compression garment can be used for Breast Augmentation, Augmentation Mammaplasty, Trans Umbilical Breast Augmentation, Transaxillary Submuscular Augmentation....
Sub Pectoral Breast Augmentation Wrap...
Bandeau Bra...
Medicine Products: